Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.
about
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma.Immunologic microenvironment and personalized treatment in multiple myeloma.Immunotherapy for multiple myeloma.T cell-based targeted immunotherapies for patients with multiple myeloma.Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma.Personalization of cancer treatment using predictive simulationMannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma.Dually modified transmembrane proteoglycans in development and disease.A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Antibody based immunotherapy for multiple myeloma: it's about time.
P2860
Q34956540-A01A1E96-25FB-45E2-A4C1-F449778AD148Q35146307-E266D40D-5DE1-42D0-A96B-51AB864D050CQ36228476-C9A2DE9F-68DD-485A-B989-AB8A28C157E3Q38108390-59A7DEBE-5FAC-4C73-B718-5598E3EA9396Q38177879-428BB03B-D935-4D6E-8801-13684ECA612BQ38246639-84E724D2-A682-4B87-BAAF-D86193699B42Q38526452-76A1F1C3-A8FB-43BD-A352-98B16A791BC8Q38914605-58621606-95BD-408A-8854-BAFFFBE9D96CQ39024097-1780BF8E-6592-458C-8410-E4D5903F55F7Q41194729-850D6C32-E4C6-4501-854C-2D39AA823C07Q47240245-B8948845-21A8-4400-BA0D-AB7AA134CC29Q47829053-812498A2-53CA-41F5-92F8-09FC4DF12E96Q48507398-DA93A914-AFFA-427C-9A6E-A16C525580C2Q49539698-58819615-CE57-46EC-BEC1-EA2467A01AE5Q53349911-9AAA07CC-F01E-489A-9E00-92FCE123A09B
P2860
Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel strategies for immunothe ...... erience and future directions.
@en
type
label
Novel strategies for immunothe ...... erience and future directions.
@en
prefLabel
Novel strategies for immunothe ...... erience and future directions.
@en
P2093
P2860
P921
P356
P1476
Novel strategies for immunothe ...... erience and future directions.
@en
P2093
Arnon Nagler
Avichai Shimoni
Ivetta Danylesko
Katia Beider
P2860
P304
P356
10.1155/2012/753407
P5008
P577
2012-05-10T00:00:00Z